Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PLAU Antikörper

PLAU Reaktivität: Human FACS Wirt: Kaninchen Chimeric unconjugated Fc fragment
Produktnummer ABIN7490722
  • Target Alle PLAU Antikörper anzeigen
    PLAU (Plasminogen Activator, Urokinase (PLAU))
    Fragment
    Fc fragment
    Reaktivität
    • 76
    • 22
    • 17
    • 4
    • 3
    • 1
    • 1
    • 1
    Human
    Wirt
    • 65
    • 12
    • 9
    • 4
    • 1
    Kaninchen
    Klonalität
    • 68
    • 20
    • 1
    Chimeric
    Konjugat
    • 48
    • 12
    • 10
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Dieser PLAU Antikörper ist unkonjugiert
    Applikation
    • 62
    • 51
    • 27
    • 15
    • 10
    • 10
    • 8
    • 6
    • 6
    • 5
    • 3
    • 3
    • 1
    • 1
    Flow Cytometry (FACS)
    Produktmerkmale
    Rabbit/Human Fc chimeric IgG1
    Aufreinigung
    Purified from cell culture supernatant by affinity chromatography
    Isotyp
    IgG1
    Top Product
    Discover our top product PLAU Primärantikörper
  • Applikationshinweise
    Flow Cyt  1:100
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
    Haltbarkeit
    12 months
  • Target
    PLAU (Plasminogen Activator, Urokinase (PLAU))
    Andere Bezeichnung
    UPA (PLAU Produkte)
    Hintergrund
    ATF, BDPLT5, QPD, u-PA, UPA, URK,
    Description: This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed.
    UniProt
    P00749
    Pathways
    Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagie, Smooth Muscle Cell Migration
Sie sind hier:
Chat with us!